E1	Modifier:T1 Modifies:T19
E2	Condition:T2 Name:T19
E3	Negation:T3 Negates:E4
E4	Condition:T4 Name:T20
E5	Condition:T5 Name:T22 Severity:T21
E6	Condition:T6 Name:T23
E7	Condition:T7 Name:T24
E9	Modifier:T9 Modifies:T26
E10	Or:T10 Arg:E9 Arg2:E11
E11	Modifier:T11 Modifies:T26
E12	Condition:T12 Name:T26
E13	Condition:T13 Name:T27
E14	Condition:T14 Name:T28 Stage:E15
E15	Eq-Comparison:T15 Value:T29
E17	Eq-Comparison:T17 Operator:T30 Value:T31
E18	Condition:T18 Name:T32
E8	Modifier:T8 Modifies:T26
E16	Age:T16 Eq-Comparison:E17
T1	Modifier 34 32	complex
T2	Condition 47 45	anal fistula
T3	Negation 112 108	Non
T4	Condition 137 133	cryptoglandular fistulas
T5	Condition 155 151	sepsis
T6	Condition 188 184	inflammatory bowel diseases
T7	Condition 209 205	simple fistulas
T9	Modifier 254 248	intersphincteric
T10	Or 258 252	and
T11	Modifier 279 273	low transsphincteric
T12	Condition 287 281	fistula
T13	Condition 304 296	pregnant
T14	Condition 322 314	ASA
T15	Eq-Comparison 325 317	IV
T17	Eq-Comparison 345 335	<18
T18	Condition 369 358	immunocompromised
T19	Condition-Name 47 45	anal fistula
T20	Condition-Name 137 133	cryptoglandular fistulas
T21	Severity 148 144	acute
T22	Condition-Name 155 151	sepsis
T23	Condition-Name 188 184	inflammatory bowel diseases
T24	Condition-Name 209 205	simple fistulas
T26	Condition-Name 287 281	fistula
T27	Condition-Name 304 296	pregnant
T28	Condition-Name 322 314	ASA
T29	Eq-Value 325 317	IV
T30	Eq-Operator 341 333	<
T31	Eq-Value 345 335	18
T32	Condition-Name 369 358	immunocompromised
T8	Modifier 235 230	subcutaneous
T16	Age 339 331	patients
A1	Severity-Value T21 severe
A2	Eq-Operator-Value T30 LT
R1	Equivalent-To Arg1:E12 Arg2:E7